Since microglia, the CNS-resident immune cells, are affected in this condition, developing immune cell-based therapies in order to improve disease prognosis and the quality of life of patients with CSF1R-related leukoencephalopathy represents a potential strategy to meet this urgent medical need. Here, CSF1R is linked to Leukoencephalopathy.